Per-O-acetylated and -benzoylated β-D-glucopyranosyl cyanides were transformed into the corresponding 5-( β-D-Glucopyranosyl)tetrazoles, 2-( β-D-glucopyranosyl)benzothiazoles, and, via the benzoylated C-( β-D-glucopyranosyl) ethyl thioformimidate, 2-( β-D-glucopyranosyl)-benzimidazoles. Acylation of the tetrazoles, either by acetic or trifluoroacetic anhydride, gave 5-( β-D-glucopyranosyl)-2-methyl-and -2-trifluoromethyl-1,3,4-oxadiazoles, respectively. Removal of the protecting groups furnished new inhibitors of glycogen phosphorylase exhibiting inhibitor constants in the micromolar range.
Introduction
Diabetes mellitus is a serious metabolic disease afflicting ~6 % of the population in Western societies. Its prevalence is dramatically increasing worldwide and the estimated number of diabetic patients is 220 million for the year 2010, indicating a 46 % enhancement in the world population during a decade. 1 This disease, characterized by chronically elevated blood glucose levels, is becoming one of the largest contributors to mortality especially due to its long term complications like retinopathy, neuropathy, and nephropathy, but first of all cardiovascular diseases.
Salt 1 was used without purification for the next reaction with 1,2-diaminobenzene to give per-O-benzoylated 2-( β-D-glucopyranosyl)benzimidazole 8. Deacylation of 5, 8, 10, and 12 under Zemplén conditions was straightforward to yield the deprotected derivatives 7, 9, 11, and 13, respectively. Deacetylation of 2 had to be carried out using a short reaction time with cooling, 19 otherwise an unseparable mixture of several unidentified products was obtained. Trifluoromethyloxadiazoles 14 and 15 did not give isolable deprotected compounds under several deacylation conditions (a similar anomaly was observed with other sugar trifluoromethyloxadiazoles 20 ). 5 R = Ac 55% 6 R = Bz 94% 7 R = H quant.
RO

d H
R = H 73%
8 R = Bz 34%
R = H 84%
10 R = Ac 68% This work a Kinetic measurements were carried out as described before.
10
Preliminary kinetic measurements with rabbit muscle glycogen phosphorylase b enzyme were performed as described before, 10 and the data are collected in Table 1 . The new compounds have inhibitor constants in the micromolar range or are not inhibitory at all (Entries 5-9). The presence of the CN group in 4 instead of CONH 2 (Entries 4 and 5) makes the inhibition stronger.
The tetrazole ring of slightly acidic character (Entry 6) is clearly unfavorable for the binding of 7 to the enzyme. The neutral aglycons in 11 and 13 result in moderate inhibitors (Entries 8 and 9). The most efficient inhibitor of this series was benzimidazole 9 (Entry 7), however, even this compound is less effective than the best glucose analog (Entry 3). Its stronger effect in comparison with 11 must be due to the amphoteric character of the heterocycle (compare Entries 7 and 8), however, the present data do not allow more precise conclusions to be drawn for the nature of its binding. Detailed kinetic studies and X-ray crystallographic evaluation of the binding modes of these compounds to GP enzymes are in progress and will be published elsewhere.
Experimental Section
General Procedures. chloride (275 mg, 5.14 mmol) and sodium azide (334 mg, 5.14 mmol) were added. The reaction mixture was refluxed for 3.5 hours, then cooled to room temperature, filtered, the residue washed with acetone, and the solvent evaporated in vacuo. The obtained syrup was placed into an ice bath and pyridine (0.12 ml) and acetic anhydride (0.24 ml) were added. The mixture was allowed to stand at room temperature for 16 hours, then it was diluted with chloroform and water. . To a solution of tetrazole 4 (500 mg, 1.25 mmol) in abs. chloroform (3 ml) trifluoroacetic anhydride (0.5 ml, 3.54 mmol) was added accompanied by a vigorous gas evolution. The reaction mixture was stirred at 60 o C for 30 minutes. Then, it was concentrated and co-evaporated with methanol (3 × 3 ml). The obtained syrup was dissolved in chloroform, washed with saturated aqueous sodium hydrogen carbonate solution and water. The organic phase was dried over magnesium sulfate, concentrated in vacuo, and the residual syrup was purified by column chromatography (eluent: hexane-ethyl acetate 3:1) and then crystallized from ethanol to give 13 as white needles 
